Literature DB >> 7469549

Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases.

G N Peters, M Wolff, C D Haagensen.   

Abstract

One hundred tubular carcinomas were reviewed, analyzed and compared with previously reported studies in the literature. Our cases were subdivided into five groups, according to the proportion of the carcinoma which was tubular. In the case of pure or almost pure tubular carcinomas (76% or more), tumor size was small, no metastases were found, no recurrences developed, and there were no deaths attributable to the carcinoma. As the proportion of the carcinoma which was tubular decreased, the size and biologic aggressiveness of the tumor increased; this it is likely that tubular carcinoma may represent an early form of carcinoma. A right-sided preponderance was found of the "pure tubular" carcinomas; and lesions of the central sector of the breast were rare in all five groups. The incidence of bilateral cancer was greater than that expected for breast cancer in general and included three patients with bilateral tubular carcinomas. On the basis of our findings, we suggest that lesions which are composed 90% or more of tubular carcinoma may be treated by simple mastectomy, and that axillary dissection is not necessary. For all carcinomas with a lower proportion of tubular elements, at least total mastectomy and axillary dissection are indicated, although the safest treatment probably is radical mastectomy.

Entities:  

Mesh:

Year:  1981        PMID: 7469549      PMCID: PMC1345032          DOI: 10.1097/00000658-198102000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

Review 1.  Lobular neoplasia (so-called lobular carcinoma in situ) of the breast.

Authors:  C D Haagensen; N Lane; R Lattes; C Bodian
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

2.  Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination.

Authors:  M D Lagios
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

3.  Tubular carcinoma of the breast.

Authors:  H S Cooper; A S Patchefsky; R A Krall
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

4.  Tubular carcinoma of the breast. Mammographic appearance and pathological correlation.

Authors:  S A Feig; G S Shaber; A S Patchefsky; G F Schwartz; J Edeiken; R Nerlinger
Journal:  Radiology       Date:  1978-11       Impact factor: 11.105

5.  Ultrastructure of tubular carcinoma of the breast.

Authors:  R A Erlandson; P H Carstens
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

6.  Tubular carcinoma: a variant of secretory breast carcinoma.

Authors:  V Eusebi; C M Betts; G Bussolati
Journal:  Histopathology       Date:  1979-09       Impact factor: 5.087

7.  Tubular carcinoma of the breast.

Authors:  H A Oberman; W J Fidler
Journal:  Am J Surg Pathol       Date:  1979-10       Impact factor: 6.394

8.  Tubular carcinoma of the breast. A study of frequency.

Authors:  P H Carstens
Journal:  Am J Clin Pathol       Date:  1978-08       Impact factor: 2.493

9.  Tubular carcinoma of the breast. Clinical, histological, and ultrastructural observations.

Authors:  H Tobon; H Salazar
Journal:  Arch Pathol Lab Med       Date:  1977-06       Impact factor: 5.534

10.  Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode.

Authors:  I Andersson; L Andrén; J Hildell; F Linell; U Ljungqvist; H Pettersson
Journal:  Radiology       Date:  1979-08       Impact factor: 11.105

View more
  10 in total

1.  Solid Tubular Carcinoma of the Breast: MR Imaging and Pathologic Correlation.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients.

Authors:  D R Brenin; M Morrow; J Moughan; J B Owen; J F Wilson; D P Winchester
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

3.  Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases.

Authors:  E S d'Amore; M J Terrier-Lacombe; J P Travagli; S Friedman; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

Review 4.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

Review 5.  Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Authors:  D J Winchester; A A Sahin; S L Tucker; S E Singletary
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

6.  MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses.

Authors:  Ravza Yılmaz; Zuhal Bayramoğlu; Selman Emirikçi; Semen Önder; Artur Salmaslıoğlu; Memduh Dursun; Gülden Acunaş; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2018-01-01

7.  Amplification of Genomic DNA for Decoy Receptor 3 Predicts Post-Resection Disease Recurrence in Breast Cancer Patients.

Authors:  Chizuko Kanbayashi; Yu Koyama; Hiroshi Ichikawa; Eiko Sakata; Miki Hasegawa; Chie Toshikawa; Naoko Manba; Mayuko Ikarashi; Takashi Kobayashi; Masahiro Minagawa; Shin-Ichi Kosugi; Toshifumi Wakai
Journal:  World J Oncol       Date:  2014-03-11

8.  Pure and Mixed Tubular Carcinoma of the Breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.

Authors:  Chanjuan Wen; Weimin Xu; Genggeng Qin; Hui Zeng; Zilong He; Sina Wang; Zeyuan Xu; Mengwei Ma; Zhendong Luo; Weiguo Chen
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

9.  Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Dae Bong Kim; Ye Ri Lee; Mi-Jung Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

Review 10.  Rare epithelial breast cancer: surgery and adjuvant therapy.

Authors:  Aida Abdelwahed; Muneer Ahmed
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.